INHIBRX BIOSCIENCES, INC. — Cash Flow Charts
9 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow
$-36M
Free Cash Flow↑+100.0% +$16K
$0
Investing Cash Flow
$0
Financing Cash Flow
$1M
Capex↓-100.0% -$16K
$0
Stock-Based Comp↓-8.0% -$239K
$3M
D&A↓-18.1% -$125K
$564K
SBC Allocated Expense↓-8.0% -$239K
$3M